Lisa Walter
Stock Analyst at RBC Capital
(0.77)
# 4,125
Out of 5,088 analysts
98
Total ratings
44%
Success rate
-3.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lisa Walter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Reiterated: Buy | $708 → $697 | $593.54 | +17.43% | 16 | Oct 22, 2026 | |
| EYPT EyePoint | Reiterated: Hold | $5 → $1 | $0.38 | +163.16% | 11 | Oct 20, 2026 | |
| KRYS Krystal Biotech | Reiterated: Buy | $400 | $324.55 | +23.25% | 2 | Oct 8, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $135 → $155 | $86.39 | +79.42% | 4 | Oct 8, 2026 | |
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $155 → $159 | $93.07 | +70.84% | 9 | Oct 8, 2026 | |
| VRDN Viridian Therapeutics | Reiterated: Buy | $38 | $24.80 | +53.23% | 9 | Oct 8, 2026 | |
| FDMT 4D Molecular Therapeutics | Reiterated: Buy | $35 | $12.78 | +173.87% | 25 | Aug 14, 2026 | |
| MGTX MeiraGTx Holdings | Reiterated: Buy | $26 → $27 | $9.71 | +178.21% | 9 | Aug 13, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $10 → $9 | $3.65 | +146.58% | 2 | Aug 6, 2026 | |
| OCUL Ocular Therapeutix | Reiterated: Buy | $30 | $7.31 | +310.40% | 11 | Aug 3, 2026 |
United Therapeutics
Oct 22, 2026
Reiterated: Buy
Price Target: $708 → $697
Current: $593.54
Upside: +17.43%
EyePoint
Oct 20, 2026
Reiterated: Hold
Price Target: $5 → $1
Current: $0.38
Upside: +163.16%
Krystal Biotech
Oct 8, 2026
Reiterated: Buy
Price Target: $400
Current: $324.55
Upside: +23.25%
Mirum Pharmaceuticals
Oct 8, 2026
Reiterated: Buy
Price Target: $135 → $155
Current: $86.39
Upside: +79.42%
Rhythm Pharmaceuticals
Oct 8, 2026
Reiterated: Buy
Price Target: $155 → $159
Current: $93.07
Upside: +70.84%
Viridian Therapeutics
Oct 8, 2026
Reiterated: Buy
Price Target: $38
Current: $24.80
Upside: +53.23%
4D Molecular Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $35
Current: $12.78
Upside: +173.87%
MeiraGTx Holdings
Aug 13, 2026
Reiterated: Buy
Price Target: $26 → $27
Current: $9.71
Upside: +178.21%
Opus Genetics
Aug 6, 2026
Reiterated: Buy
Price Target: $10 → $9
Current: $3.65
Upside: +146.58%
Ocular Therapeutix
Aug 3, 2026
Reiterated: Buy
Price Target: $30
Current: $7.31
Upside: +310.40%